From Liston Street Pulse:
Array Biopharma Inc. (ARRY) was paid $5 million by its partner AstraZenica PLC. The payment was made in relation to the lung cancer drug candidate that is being tested on human patients. The drug candidate was also being tested on other forms of lung cancer. At present more than 600 […]
The post Array Biopharma was paid $5 million by AstraZenica appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015